# Tarsus Pharmaceuticals, Inc. (TARS)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/TARS/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 335.97M | $ -25.52M | $ 32.23M | $ 88.66M | $ 346.73M |
| 2025 | $ 462.15M | $ -68.01M | $ -22.84M | $ 93.64M | $ 343.43M |
| 2024 | $ 192.30M | $ -121.46M | $ -94.17M | $ 72.45M | $ 224.53M |
| 2023 | $ 18.86M | $ -146.93M | $ -132.99M | $ 30.22M | $ 196.99M |
| 2022 | $ 28.84M | $ -69.36M | $ -55.34M | $ 20.21M | $ 192.90M |
| 2021 | $ 67.79M | $ -16.60M | $ 3.76M | $ 1.89M | $ 166.73M |
| 2020 | $ 0 | $ -34.16M | $ -27.51M | $ 831.0K | $ 165.98M |
| 2019 | $ 0 | $ -2.70M | $ -1.81M | $ 164.0K | $ -6.01M |
| 2018 | $ 0 | $ -871.0K | $ -785.8K | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.26 |
| Liabilities / Eq | 0.76 |
| Current Ratio | 3.20 |

## Other views

- [Metrics](https://sponda.capital/en/TARS.md)
- [Charts](https://sponda.capital/en/TARS/charts.md)
- [Compare](https://sponda.capital/en/TARS/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.